Skip to main content
KIDSOrthoPediatrics Corp.Sell5.4·$31.74
SellModerate Confidence

Thesis pillars

  • Gaap Loss But Fcf Positive→Stable
  • Accelerating Revenue Growth→Stable
  • Perfect Earnings Beat Streak→Stable
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Oct 24, 2026, based on the 10-K filed Mar 4, 2026

Full reasoning →

Open full analysis

OrthoPediatrics Corp. (KIDS) Stock Analysis

Range Bound setup

SellVALUE-TRAP 2/5GrowthQualityModerate Confidence

Healthcare · Medical Devices

Sell if holding. Analyst target reached at $31.74 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Value-trap signals (2/5): Margin compression (op margin -8.1%), Material insider selling (21 sells, 5.64% of cap).

OrthoPediatrics designs, develops and markets orthopedic implants, instruments and specialized braces built specifically for children, selling to hospitals across the United States and more than 75 international markets through independent sales agencies, distributors and direct... Read more

$31.74-7.1% A.UpsideScore 5.4/10#28 of 62 Medical Devices
QualityF-score8 / 9FCF yield1.19%
Stop $29.52Analyst target $29.47(reached)A.R:R -0.5:1
Analyst consensus$33.88+6.7%8 analysts with price targets
$31.74price
$33.88mean
$27
$45

Sell if holding. Analyst target reached at $31.74 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Value-trap signals (2/5): Margin compression (op margin -8.1%), Material insider selling (21 sells, 5.64% of cap). Chart setup: RSI 56 mid-range, Bollinger mid-band. Score 5.4/10, moderate confidence.

Passes 5/8 gates (no SEC red flags, news events none recent, earnings proximity 95d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and clean insider activity. Suitability: aggressive.

10-K grounded · weekly refresh

About OrthoPediatrics Corp.

About OrthoPediatrics Corp.

OrthoPediatrics generated $236.3 million in revenue for fiscal 2025, up from $204.7 million in 2024 and $148.7 million in 2023, marketing 87 surgical implant and bracing systems across trauma and deformity correction, scoliosis, and sports medicine — the three largest categories of the pediatric orthopedic market. The company sells to hospitals in the United States and more than 75 international countries, targeting a segment it estimates represents a $6.2 billion global opportunity, including $2.8 billion domestically.

The company sells through a hybrid channel of direct sales representatives, more than 30 independent U.S. sales agencies and over 80 international stocking distributors; sales agencies alone generated 56% of global revenue in fiscal 2025, down slightly from 59% in 2024. Implants and surgical instrumentation are produced under a contract manufacturing model, while orthotic and prosthetic bracing products are manufactured in-house, including through the 2024-acquired Boston Brace International subsidiary, which has continued acquiring O&P clinics in states including Virginia, Maryland, Florida, Colorado, North Carolina and New York through 2025. OrthoPediatrics also licenses third-party technology, including an extended distribution agreement for FIREFLY Technology running through 2030 and a 7D Surgical FLASH Navigation license extended through 2028, supplementing organic product development with in-licensed surgical navigation tools.

Show full overview

OrthoPediatrics' products remain subject to Humanitarian Device Exemption requirements and Institutional Review Board oversight, a regulatory pathway built for devices treating small patient populations — a fitting description for a market where the Pediatric Orthopaedic Society of North America counted roughly 1,500 members in 2025 versus approximately 33,400 U.S. surgeons focused on adults. The 10-K also flags dependency on its distribution network: the company's independent sales agencies and distributors, rather than direct hires, generated the majority of revenue, and losing that network could impair its ability to reach hospitals.

See also: Healthcare · Medical Devices

From OrthoPediatrics Corp.'s most recent 10-K filing, extracted July 6, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated Nov 9, 2026

Recent Developments — OrthoPediatrics Corp.

Latest item Nov 9, 2026 · Generated 2026-11-22T11:52:07Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Feb 25, 202795d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.8
Strong earnings beat streak (3/4)
Strong growth profile
Risks
Analyst target reached - limited upside remaining
Value-trap signals (2/5): Margin compression (op margin -8.1%), Material insider selling (21 sells, 5.64% of cap)

Key Metrics

P/E (TTM)—
P/E (Fwd)-42.1
Mkt Cap$829M
EV/EBITDA793.1
Profit Mgn-12.8%
ROE-9.8%
Rev Growth18.6%
Beta0.87
DividendNone
Analysts with ratings14

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.50bullish
IV66%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

10 dimensions · all in-band

GatesMomentum 4.3<4.5A.R:R -0.5=NEGATIVEINSIDER 5.64%=EXTREMENo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 95d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
56 · Neutral
↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $23.56Resistance $34.53

Price Targets

A.Upside-7.1%
A.R:R-0.5:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeCrisis

Risk Alerts

! Target reached (-7.1% upside)
! momentum at 4.3 (below the engine's 4.5 threshold)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2027-02-25 (95d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is KIDS stock a buy right now?

Sell if holding. Analyst target reached at $31.74 — A.R:R is negative (-0.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Value-trap signals (2/5): Margin compression (op margin -8.1%), Material insider selling (21 sells, 5.64% of cap). Chart setup: RSI 56 mid-range, Bollinger mid-band. Prior stop was $29.52. Score 5.4/10, moderate confidence.

What is the KIDS stock price target?

Analyst target $29.47 reached (−7.1% from $31.74); no take-profit level is published. Prior stop was $29.52. Stop-loss: $29.52.

What are the risks of investing in KIDS?

Analyst target reached - limited upside remaining; Value-trap signals (2/5): Margin compression (op margin -8.1%), Material insider selling (21 sells, 5.64% of cap).

Is KIDS overvalued or undervalued?

OrthoPediatrics Corp. trades at a P/E of N/A (forward -42.1). TrendMatrix value score: 5.7/10. Verdict: Sell.

What do analysts say about KIDS?

14 analysts rate KIDS, with a consensus score of 4.1/5. 8 analysts publish price targets averaging $34.

What does OrthoPediatrics Corp. do?OrthoPediatrics designs, develops and markets orthopedic implants, instruments and specialized braces built...

OrthoPediatrics designs, develops and markets orthopedic implants, instruments and specialized braces built specifically for children, selling to hospitals across the United States and more than 75 international markets through independent sales agencies, distributors and direct sales representatives. The company generated $236.3 million in revenue for fiscal 2025, up from $204.7 million in 2024, using contract manufacturers for implants and in-house production for its orthotic and prosthetic bracing lines.

Related stocks: DCTH (Delcath Systems, Inc.) · MASS (908 Devices Inc.) · BVS (Bioventus Inc.) · SENS (Senseonics Holdings, Inc.) · BWAY (Brainsway Ltd.)
Home › Stocks › KIDS

Latest news

Latest News

CNBC109d ago
Moomoo109d agoAnalyst
Youth Today109d ago
TradingView109d ago
MarketBeat109d agoEarnings
Yahoo Finance109d ago
MarketBeat109d agoEarnings
MarketBeat110d agoEarnings
Finance.yahoo.com110d agoEarnings
Yahoo Finance110d agoEarnings
Yahoo Finance110d ago
Investing.com110d agoEarnings
Investing.com UK110d agoEarnings
Marketscreener.com110d agoEarnings
Finance.yahoo.com110d agoEarnings
Yahoo Finance110d agoEarnings
Forbes108d ago
KVOM 101.7108d ago
Morehead State Public Radio114d ago
EdSource114d ago
Loading more...